What’s Beximco Pharmaceuticals Limited Downside After Today’s Huge Decline?

 What's Beximco Pharmaceuticals Limited Downside After Today's Huge Decline?

The stock of Beximco Pharmaceuticals Limited (LON:BXP) is a huge mover today! The stock increased 6.56% or GBX 2.95 on November 10, hitting GBX 47.95. About 28,805 shares traded hands. Beximco Pharmaceuticals Limited (LON:BXP) has risen 87.13% since April 13, 2016 and is uptrending. It has outperformed by 81.48% the S&P500.
The move comes after 7 months negative chart setup for the GBX 32.03 billion company. It was reported on Nov, 10 by Barchart.com. We have GBX 45.07 PT which if reached, will make LON:BXP worth GBX 1.92B less.

Another recent and important Beximco Pharmaceuticals Limited (LON:BXP) news was published by Uk.Finance.Yahoo.com which published an article titled: “Beximco Pharmaceuticals Limited (BXP.L)” on March 30, 2014.

Beximco Pharmaceuticals Limited is engaged in the manufacturing and marketing of generic pharmaceuticals formulation products, including intravenous fluids and active pharmaceutical ingredients (APIs). The company has a market cap of 32.03 billion GBP. The Firm also provides contract manufacturing services. It has a 0.1 P/E ratio. The Firm produces approximately 300 generic medicines, which are available in over 500 different presentations and the portfolio encompasses various key therapeutic categories, including antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, dermatology and gastrointestinal.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment